Evidence map›Paper›PMID 42315934›Full record

ArticleAlimentary pharmacology & therapeutics2026

Editorial: Two Common Risks, One Greater Harm-Diabetes and Alcohol in Steatotic Liver Disease. Authors' Reply.

Ruoqi Zhou, Yu Shi, Xinrong Zhang

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ruoqi ZhouState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0009-0003-0521-8711
Yu ShiState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0000-0002-9392-7176
Xinrong ZhangGuangdong Provincial Key Laboratory of Food, Nutrition and Health, and Department of Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, China.

Funding

Fundamental Research Funds for the Central Universities 226-2023-00127Key Research and Development Program of Zhejiang Province 2026C02A1172Medical Science and Technology Project of Zhejiang Province 2022RC141National Natural Science Foundation of China 2025HY00260123National Natural Science Foundation of China 81870425National Natural Science Foundation of China 82570717State Key Laboratory for Diagnosis and Treatment of Infectious Diseases 202503Young Scholar Training Program of Sun Yat-Sen University 26hytd010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42315934
PMCPMC13356287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.